Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Oxford American Handbook of Ophthalmology_Tsai, Denniston, Murray_2011

.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
11 Mб
Скачать

516 CHAPTER 16 Neuro-ophthalmology

Anatomy and physiology (2)

Ocular motor nerves

Third nerve

The CN III nucleus lies in the midbrain anterior to the periaqueductal gray matter at the level of the superior colliculus. It consists of a single central nucleus innervating both levator palpebrae superioris (LPS) muscles, and separate subnuclei for each superior rectus (SR) (contralateral innervation), medial rectus, inferior rectus (MR), and inferior oblique (IO) (all ipsilateral innervation).

The CN III fasciculus travels anteriorly through the medial longitudinal fasciculus (MLF), the red nucleus, and the cerebral peduncle. On leaving the midbrain, it emerges within the interpeduncular fossa and passes anteriorly beneath the posterior cerebral artery, above the superior cerebellar artery, and lateral to the posterior communicating artery (Fig. 16.1). It travels within the lateral wall of the cavernous sinus, dividing into superior and inferior branches that enter the orbit via the superior orbital fissure and annulus of Zinn.

The superior branch innervates LPS and SR, whereas the inferior branch innervates MR, IR, IO, and the pupillary sphincter. Parasympathetic fibers from the Edinger–Westphal nucleus travel in the IO branch as far as the ciliary ganglion and then in the short ciliary nerves to the globe, where they innervate the ciliary muscle and pupillary sphincter.

Fourth nerve

The CN IV nucleus lies just below the CN III nucleus in the lower midbrain at the level of inferior colliculus. The fasciculus decussates within the anterior medullary velum and exits the midbrain posteriorly.

It then curves round the midbrain, passes anteriorly between the posterior cerebral and superior cerebellar arteries, and travels within the lateral wall of the cavernous sinus (inferolateral to CN III, superior to CN V1). It then enters the orbit through the superior orbital fissure (but superior to the annulus of Zinn) and terminates in the superior oblique muscle.

Sixth nerve

The CN VI nucleus lies in the lower pons anterior to the fourth ventricle at the level of the facial colliculus. Although most axons innervate the ipsilateral LR, about 40% of axons project via the MLF to the contralateral MR subnucleus. The fasciculus travels anteriorly through the medial leminiscus and corticospinal tract, just medial to the trigeminal nuclear complex and vestibular nuclei.

After emerging at the pontomedullary junction, it ascends in the subarachnoid space between the pons and the clivus, before turning anterior over the petrous apex of the temporal bone and under the petroclinoid ligament to enter the cavernous sinus. Here it runs within the sinus itself just lateral to the ICA and inferomedial to CN III, IV, and V1, which run in the sinus wall. It then enters the orbit via the superior orbital fissure and annulus of Zinn to terminate in the LR muscle.

Ophthalmology of Handbook American Oxford : .C James Tsai, eISBN:9780195393446; 266418790Account:

III nerve

Posterior communicating artery

 

 

AL

 

IV nerve

VI nerve

Figure 16.1 Cranial nerves III, IV, and VI.

 

 

 

 

 

 

 

 

 

517 (2) PHYSIOLOGY AND ANATOMY

518 CHAPTER 16 Neuro-ophthalmology

Anatomy and physiology (3)

Autonomic supply

Sympathetic

The first-order neurons originate in the posterior hypothalamus and descend through the brainstem to synapse in the spinal cord at the ciliospinal center of Budge (C8-T2).

The second-order neurons emerge anteriorly in the ventral root (close to the lung apex) and then ascend in the sympathetic chain to synapse at the superior cervical ganglion.

The third-order neurons ascend along the ICA to the cavernous sinus and then via the nasociliary branch of CN V1 into the orbit and subsequently the long ciliary nerves, terminating in the dilator pupillae.

Parasympathetic

The light and near reflexes are both mediated by the parasympathetic supply from the Edinger–Westphal nucleus. The afferent arm for the light reflex is by 1) retinal ganglion cells that synapse in the ipsilateral pretectal nucleus and then 2) interneurons that innervate bilateral Edinger– Westphal nuclei. The inputs for the near reflex are less well-defined but probably include cortical influences (frontal and occipital lobes) mediated by a midbrain center (anterior to the pretectal nucleus).

The efferent arm for both reflexes comprise 1) preganglionic neurons from the Edinger–Westphal nucleus that travel in CN III and then the inferior division of CN III to the inferior oblique before synapsing at the ciliary ganglion, and 2) postganglionic neurons that run via the short ciliary nerves to terminate in the constrictor pupillae and ciliary muscle.

Cerebrospinal fluid (CSF)

CSF is produced by the choroid plexus in the lateral ventricles and the third ventricle. It flows from the lateral ventricles via the foramen of Munro to the third ventricle and then via the aqueduct of Sylvius to the fourth ventricle. From there, it leaves either via the lateral foramina of Luschka or the medial foramen of Magendie to bathe the spinal cord and cerebral hemispheres in the subarachnoid space.

CSF is then absorbed into the cerebral venous system by the arachnoid granulations. The subarachnoid space is continuous with the optic nerve sheath.

OPTIC NEUROPATHY: ASSESSMENT 519

Optic neuropathy: assessment

The optic nerve is vulnerable to injury from numerous local and systemic diseases (see Table 16.1). Clinical features often include dVA, relative or complete afferent pupillary defect, dlight sensitivity, dcolor vision, visual field defects, and optic disc abnormalities, such as pallor.

Table 16.1 An approach to assessing optic nerve disease

Visual symptoms

Blurring, washout of colors, blind spots; may be

 

 

asymptomatic; check duration, speed of onset and

 

 

recovery, precipitants, associations (diplopia, proptosis,

 

 

red eye)

 

POH

Previous or current eye disease; refractive error

 

PMH

Vascular risk factors and disease; neurological disease

 

 

(e.g., MS); connective tissue disease (e.g., SLE, RA);

 

 

granulomatous disease (e.g., sarcoidosis, TB)

 

Review of

Detailed review of all systems; particularly any headache or

 

systems

abnormalities of sensation, motor system, speech, balance,

 

 

or hearing

 

SH

Driver; profession; diet, alcohol intake, toxin exposure

 

 

(e.g., lead, tin, or carbon monoxide)

 

FH

Family members with visual problems

 

Drug history

Previous or current toxic drugs (e.g., anti-TB)

 

Allergy history

Allergies or relevant drug contraindications

 

Visual acuity

Best-corrected/pinhole/near

 

Visual function

Check for RAPD, color vision, red desaturation, visual

 

 

fields (formal perimetry)

 

Orbit

Proptosis

 

AS

Features suggestive of glaucoma, uveitis, CCF

 

Tonometry

IOP

 

Optic disc

Size, cup, color, edema; congenital abnormalities;

 

 

flat, elevated, tilted, crowding; peripapillary edema or

 

 

hemorrhages; retinociliary collateral vessels

 

 

 

Macula

Abnormalities that may cause central scotoma

 

 

Fundus

Abnormalities (e.g., retinoschisis) that may cause

 

 

peripheral field loss; posterior uveitis, or vasculitis

 

Vessels

Arteriosclerosis, hypertensive changes, occlusions

 

CNS/PNS

Cranial nerves (including ocular motility), sensory, motor,

 

 

cerebellar function, speech, mental state

 

CVS

Pulse, heart sounds, carotid bruits

 

Systemic review

Including respiratory, gastrointestinal, genitourinary,

 

 

ENT systems

 

 

 

 

 

Consider also retinoscopy to rule out refractive error.

520 CHAPTER 16 Neuro-ophthalmology

Diagnosis is more difficult in early symmetric disease where there may be no objective signs. Electrodiagnostic tests are often helpful in such cases. Also, typical optic neuropathy features may be seen in other diseases (e.g., central scotoma, dcolor vision, or secondary optic atrophy in retinal disorders). The challenge is thus first to recognize the optic neuropathy and then elucidate the cause (Tables 16.2 and 16.3).

Unexplained optic neuropathy requires urgent investigation (p. 523) to elucidate the cause and rule out serious disease such as compression secondary to a tumor.

Table 16.2 Clinical features of optic nerve vs. macular disease

 

Optic neuropathy

Macular disease

History

 

 

Main complaint

Gray/darkness

Distortion

Scotoma

Negative

Positive

Associated

May have retrobulbar pain,

May have micropsia,

symptoms

e.g., on eye movement

hyperopic shift

 

 

 

Examination

 

 

VA

Variable d

dd

Color vision

dor dd

Normal or mild d

RAPD

+

 

 

 

Testing

 

 

Perimetry

Central, centrocecal, arcuate,

Central scotoma

 

or altitudinal defects

 

Amsler grid

Scotoma

Metamorphopsia

VEP latency

i

Normal or mild i

 

 

 

 

 

OPTIC NEUROPATHY: ASSESSMENT

521

 

 

 

 

Table 16.3 Differential diagnosis of acute or subacute optic

 

 

neuropathy

 

 

 

Optic neuritis

Ages 20–50 years, unilateral, dVA over hours/days,

 

 

(typical)

recovery starts within 2 weeks, retrobulbar pain

 

 

Compressive

Progressive dVA, disc pallor ± pain, involvement of other

 

 

 

 

local structures

 

 

Sphenoid sinus

Persistent severe pain, pyrexia, history of sinusitis; consider

 

 

disease

fungal disease in the immunosuppressed or in diabetic

 

 

 

 

ketoacidosis

 

 

Sarcoidosis

Progressive d VA ± uveitis, symptoms or signs of

 

 

 

 

sarcoidosis, very steroid sensitive

 

 

Vasculitis (e.g., SLE)

Progressive d VA ± uveitis, symptoms or signs of vasculitis

 

 

Syphilis

Progressive d VA ± uveitis; symptoms or signs of syphilis;

 

 

 

 

may be HIV+

 

 

Anterior ischemic

Sudden painless d VA, altitudinal field loss, swollen optic

 

 

optic neuropathy

disc (may be segmental), usually older age group; features

 

 

(AION)

of arteritic or nonarteritic disease

 

 

Toxic or nutritional

Slowly progressive symmetrical dVA with central

 

 

 

 

scotomas; relevant nutritional, therapeutic, or toxic history

 

 

Leber’s hereditary

Severe sequential dVA over weeks or months,

 

 

optic neuropathy

telangiectatic vessels around optic disc (acutely); usually

 

 

(LHON)

young adult males; family history

 

 

Postviral

Often bilateral dVA few weeks postviral or

 

 

demyelination

postvaccination, usually in children or young adults; ±

 

 

 

 

acute disseminated encephalomyelitis (ADEM)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

522 CHAPTER 16 Neuro-ophthalmology

Optic neuritis: assessment

Inflammation of the optic nerve may be divided into papillitis (where the disc is swollen), retrobulbar neuritis (where the disc is spared), and neuroretinitis (with retinal involvement, “macular star”). The most common cause of optic neuritis is demyelination, although a number of important differential diagnoses must be considered.

Acute demyelinating optic neuritis

Incidence within the general population is around 5/100, 000/year, but it occurs in up to 70% of patients with known MS. Most of the patients are female (F:M 3:1) and are usually aged 20–50 years. The disease is usually unilateral, although bilateral involvement may be seen in children.

Clinical features

Rapid dVA over hours or days (rarely become NPL); recovery starts within 2 weeks and may continue for a few months; dcontrast

sensitivity, dcolor vision, field loss (variable pattern), retrobulbar pain (present in 90%; often worse on eye movement, usually precedes dVA), photopsia.

RAPD (may be absent if pre-existing contralateral disease), disc swelling (only 1/3 of cases); disc should not be pale in the acute stages of a first episode; may have few hemorrhages, retinal exudates, and mild vitritis.

Investigations

If the episode is entirely typical (Box 16.1), the diagnosis may be made on clinical grounds alone.

Box 16.1 Features of typical optic neuritis (from Optic Neuritis Treatment Trial)

Ages 20–50 years

Unilateral

Worsens over hours/days

Recovery starts within 2 weeks

Retrobulbar pain (may be worse on eye movement)

dColor vision

RAPD

If the episode is atypical, investigate to rule out a progressive optic neuropathy (see below).

Treatment

This is indeed controversial. Intravenous methylprednisolone hastens visual recovery but does not affect long-term outcome (conclusion of Optic Neuritis Treatment Trial). On this basis, IV steroid treatment may be offered to those with poor vision in the other eye or with severe pain.

OPTIC NEURITIS: ASSESSMENT 523

In those at high risk (>2 plaques on MRI), interferon B1a appears to reduce or at least delay both the clinical diagnosis of MS (i.e., a further significant demyelinating episode) and the accumulation of further silent MRI lesions (CHAMPS: Controlled High-risk Avonex MS Prevention Study; ETOMS: Early Treatment of MS Study).

Prognosis

Visual recovery

All patients will have some improvement, with >90% attaining 20/30 in the affected eye. However, even if RAPD resolves and VA recovers to 20/20 abnormalities of color perception, contrast sensitivity, stereopsis, or field may persist. Around one-third of patients have a further episode (either eye) within 5 years. On MRI, poor visual prognosis is associated with length of optic nerve involvement and intracanalicular segment involvement.

Probability of developing MS

Risk factors are female sex, multiple white matter lesions on MRI, and CSF oligoclonal bands. Five-year probability of MS increases from 16% with a normal MRI to 51% if >2 white matter lesions are found.

Devic’s disease

Devic’s disease (neuromyelitis optica) is characterized by bilateral optic neuritis with transverse myelitis. Patients present with rapid, severe bilateral dVA and paraplegia.

Atypical optic neuritis

If an acute optic neuropathy does not fulfill the criteria for typical optical neuritis (e.g., not improving at 2 weeks), it must be investigated further to exclude a compressive lesion or other serious pathology (see Table 16.3, p. 521).

Investigations may include MRI (gadolinium enhanced), CXR, CBC, ESR, CRP, UA, Glu, LFT, ACE, ANA, ANCA, syphilis serology, LHON, and LP (CSF analysis for microscopy, protein, glucose, oligoclonal bands, and cytology).

A diagnosis of demyelinating disease is supported by typical white matter plaques on MRI and oligoclonal bands in CSF (but not in serum).

524 CHAPTER 16 Neuro-ophthalmology

Anterior ischemic optic neuropathy (1)

AION is a significant cause of acute visual loss in the elderly population, affecting up to 10/100,000/year of those over 50 years of age. In 5–10% of cases, the etiology is arteritic (giant cell arteritis); in 90–95% it is nonarteritic. Giant cell arteritis (GCA) is an ophthalmic emergency requiring immediate assessment and appropriate institution of systemic steroid treatment.

Arteritic AION

In arteritic AION, short posterior ciliary artery vasculitis leads to ischemic necrosis of the optic nerve head.

Clinical features

Sudden dVA (<20/200 in 76%); headache, scalp tenderness, jaw claudication, weight loss, night sweats, myalgia (association with polymyalgia rheumatica); may have a warning episode of transient dVA (short obscurations or longer amaurosis fugax–like episodes).

RAPD, swollen disc (typically pale; rarely segmental), ± peripapillary hemorrhages and cotton wool spots, abnormal temporal arteries (thickened, tender, nonpulsatile).

Associations: CRAO, BRAO, cilioretinal artery occlusion, CN III, IV, VI palsy.

Investigations

Immediate ESR, CRP, CBC: iESR, iCRP, and iPlt are all supportive of GCA (Table 16.4). Consider urgent temporal artery biopsy (aim to perform it within a few days, although positive results may be obtained

up to 7 days after corticosteroid treatment). ESR should be interpreted in context (Box 16.2). See also diagnostic criteria in Box 16.3.

Treatment

Give immediate adequate steroid treatment (e.g., 1 g methylprednisolone IV 1x/day for 1–3 days) followed by oral prednisolone 1–2 mg/kg 1x/day). Aspirin may have additional benefit. Once disease is controlled, steroids may be titrated according to symptoms and inflammatory markers (CRP responds more quickly than ESR).

Treatment may last several years so osteoporosis prophylaxis is important. The elderly are particularly vulnerable to the side effects of steroids.

Prognosis

The risk of second eye involvement ranges from 10% (if treated) to 95% (untreated). Other complications of GCA include TIA, stroke, neuropathies, thoracic artery aneurysms, and death.

ANTERIOR ISCHEMIC OPTIC NEUROPATHY (1) 525

Table 16.4 Investigations in GCA

 

Sensitivity

Specificity

Histological

 

100%

Temporal artery biopsy

80–90% (unilateral biopsy)

 

95–97% (bilateral biopsy)

 

Hematological

 

 

Biopsy-proven GCA vs. normal controls (Hayreh et al.)*

 

iESR

92%

94%

iCRP

100%

 

iESR + iCRP

 

97%

Biopsy-positive vs. biopsy-negative patients with clinical suspicion of GCA (Foroozan et al.)**

iESR + iPlt

51%

91%

*Hayreh et al. defined iESR as >47mm/h and iCRP > 2.45mg/dL. Am J Ophthalmol 1997; 123:392–395.

**Foroozan et al. defined iESR as > age/2 for men or > (age +10)/2 for women and iPlt as >400 x103/μL. Ophthalmology 2002; 109:1267–1271.

Box 16.2 Interpretation of ESR results

The upper limit of normal for ESR has traditionally been approximated to age/2 for men and (age + 10)/2 for women. However, it is increasingly thought that this upper limit may be rather generous: a lower upper limit may need to be considered.

ESR will be lower in the presence of polycythemia, hemoglobinopathies, hereditary spherocytosis, congestive cardiac failure, and anti-inflammatory medications.

ESR will be elevated by anemia, malignancy, infection, and inflammation.

Box 16.3 ACR traditional criteria (1990) for diagnosis of GCA

Age 50 years at disease onset

New onset of localized headache

Temporal artery tenderness or decreased pulse

ESR 50 mm/h

Arterial biopsy with necrotizing arteritis with a predominance of mononuclear cell infiltrates or granulomatous process with multinuclear giant cells

The presence of three or more out of five of the above criteria was associated with 93.5% sensitivity and 91.2% specificity.